Bjerkholt Eric's Form 4 filing
Mirum Pharmaceuticals, Inc. (MIRM) · filed Jun 9, 2026
- Accession no.
- 0001197350-26-000007
- Filed
- Jun 9, 2026
- Trade date
- Jun 8-9, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $469.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bjerkholt EricCIK 0001197350 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Common Stock | SSaleDisposed | −2,258 | $92.84 | −$209,632.72 | 47,530 | Direct | |
| Jun 8, 2026 | Common Stock | SSaleDisposed | −1,175 | $93.95 | −$110,391.25 | 46,355 | Direct | |
| Jun 8, 2026 | Common Stock | SSaleDisposed | −1,567 | $95.12 | −$149,053.04 | 44,788 | Direct | |
| Jun 9, 2026 | Common Stock | MOption exerciseAcquired | +2,393 | $26.49 | +$63,390.57 | 47,181 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Common Stock | MOption exerciseDisposed | −2,393 | $0.00 | $0 | 26,653 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.